Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity
Tina Bagratuni(National and Kapodistrian University of Athens), Meletios Α. Dimopoulos(Korea University)
Cited by 29
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k